Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001887446 | SCV002166732 | benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002334834 | SCV002644021 | uncertain significance | Inborn genetic diseases | 2021-06-21 | criteria provided, single submitter | clinical testing | The p.R1662C variant (also known as c.4984C>T), located in coding exon 45 of the KIF1A gene, results from a C to T substitution at nucleotide position 4984. The arginine at codon 1662 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |